History and future of leptin: Discovery, regulation and signaling.

Energy expenditure Feeding Glucose homeostasis Leptin receptor Leptin transport Neuronal circuits Reward

Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 31 07 2024
revised: 27 08 2024
accepted: 04 09 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 8 9 2024
Statut: aheadofprint

Résumé

The cloning of leptin 30 years ago in 1994 was an important milestone in obesity research. Prior to the discovery of leptin, obesity was stigmatized as a condition caused by lack of character and self-control. Mutations in either leptin or its receptor were the first single gene mutations found to cause severe obesity, and it is now recognized that obesity is caused mostly by a dysregulation of central neuronal circuits. Since the discovery of the leptin-deficient obese mouse (ob/ob) the cloning of leptin (ob aka lep) and leptin receptor (db aka lepr) genes, we have learned much about leptin and its action in the central nervous system. The first hope that leptin would cure obesity was quickly dampened because humans with obesity have increased leptin levels and develop leptin resistance. Nevertheless, leptin target sites in the brain represent an excellent blueprint to understand how neuronal circuits control energy homeostasis. Our expanding understanding of leptin function, interconnection of leptin signaling with other systems and impact on distinct physiological functions continues to guide and improve the development of safe and effective interventions to treat metabolic illnesses. This review highlights past concepts and current emerging concepts of the hormone leptin, leptin receptor signaling pathways and central targets to mediate distinct physiological functions.

Identifiants

pubmed: 39245434
pii: S0026-0495(24)00253-1
doi: 10.1016/j.metabol.2024.156026
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

156026

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Heike Muenzberg reports financial support was provided by National Institutes of Health. Christopher D Morrison reports financial support was provided by National Institutes of Health. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Heike Münzberg (H)

Pennington Biomedical Research Center, LSU System, Baton Rouge, LA, United States of America. Electronic address: Heike.Munzberg@pbrc.edu.

Steven B Heymsfield (SB)

Pennington Biomedical Research Center, LSU System, Baton Rouge, LA, United States of America.

Hans-Rudolf Berthoud (HR)

Pennington Biomedical Research Center, LSU System, Baton Rouge, LA, United States of America.

Christopher D Morrison (CD)

Pennington Biomedical Research Center, LSU System, Baton Rouge, LA, United States of America.

Classifications MeSH